Lipum Financial Statements From 2010 to 2024
| LIPUM Stock | SEK 7.25 0.35 5.07% |
Check Lipum AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lipum AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Lipum financial statements analysis is a perfect complement when working with Lipum AB Valuation or Volatility modules.
Lipum |
Lipum AB Company Return On Asset Analysis
Lipum AB's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Lipum AB Return On Asset | -0.91 |
Most of Lipum AB's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lipum AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Lipum AB has a Return On Asset of -0.9118. This is 89.58% lower than that of the Healthcare sector and 96.14% lower than that of the Biotechnology industry. The return on asset for all Sweden stocks is notably higher than that of the company.
Lipum AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Lipum AB's current stock value. Our valuation model uses many indicators to compare Lipum AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lipum AB competition to find correlations between indicators driving Lipum AB's intrinsic value. More Info.Lipum AB is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lipum AB's earnings, one of the primary drivers of an investment's value.About Lipum AB Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Lipum AB income statement, its balance sheet, and the statement of cash flows. Lipum AB investors use historical funamental indicators, such as Lipum AB's revenue or net income, to determine how well the company is positioned to perform in the future. Although Lipum AB investors may use each financial statement separately, they are all related. The changes in Lipum AB's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Lipum AB's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Lipum AB Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Lipum AB. Please read more on our technical analysis and fundamental analysis pages.
Lipum AB , a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. The company was founded in 2010 and is headquartered in Ume, Sweden. Lipum AB is traded on Stockholm Stock Exchange in Sweden.
Pair Trading with Lipum AB
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lipum AB position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipum AB will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Lipum AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lipum AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lipum AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lipum AB to buy it.
The correlation of Lipum AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lipum AB moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lipum AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lipum AB can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Lipum Stock Analysis
When running Lipum AB's price analysis, check to measure Lipum AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipum AB is operating at the current time. Most of Lipum AB's value examination focuses on studying past and present price action to predict the probability of Lipum AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipum AB's price. Additionally, you may evaluate how the addition of Lipum AB to your portfolios can decrease your overall portfolio volatility.